Zurich’s Züri Can pilot is giving cannabis reformers something stronger than slogans. New interim findings show regulated, nonprofit access reduced several reported health problems while pulling demand away from the illegal market, giving Switzerland fresh evidence for national cannabis reform and putting prohibition panic on weaker ground.
Vegas Knew, Vegas Looked Away
Las Vegas sold tourists the illusion of legal cannabis while fake dispensary style hemp shops operated near the Strip. Vegas Knew, Vegas Looked Away exposes how Nevada’s casino separation rules, weak hemp oversight, delayed Clark County action, and tourist confusion created a loophole economy hiding in plain sight.
CANNABIS LIES Vol. 10: The Medical Lie
For decades, federal policy claimed cannabis had no accepted medical use while opioid prescriptions moved through the health care system by the tens of millions. Cannabis Lies Vol. 10 exposes the contradiction behind Schedule I, blocked research, medical cannabis patients, and the institutions that spent years pretending politics was medicine.
Jersey’s New Cash Crop
Jersey reinvented itself. A forty-five square mile island once known for offshore finance is now exporting pharmaceutical-grade cannabis into Germany’s booming medical market. With strict regulation, heavy investment, and a government eager for diversification, Jersey has become an unlikely European powerhouse. The contradiction between local policing and global commerce tells the real story.
Australia Cracks Down on Medical Cannabis
Australia’s medical cannabis system expanded rapidly through telehealth and high-volume prescribing. Now regulators are tightening oversight. The TGA and AHPRA are increasing scrutiny on prescribing practices, signaling a shift from rapid patient access toward stricter clinical control that could reshape how doctors prescribe and how patients obtain treatment.
Cannabis Study Sparks Fear Among the Uninformed
A McMaster-led analysis of two Canadian mental health surveys is getting recycled as a weed panic story, even though the design can only show association. This piece breaks down what the data can actually support, what it cannot prove, and how headlines turn survey correlations into causal claims that fuel stigma, bad policy, and lazy coverage.